During the past decade, NYU Langone Hospital-Long Island Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Hospital-Long Island Oncology" #1 collaborator was "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NYU Langone Hospital-Long Island Oncology" are "Advanced Solid Tumors" (1 trials), "Breast Cancer" (1 trials), "Chronic Myeloid Leukemia" (1 trials), "Colorectal Cancer" (1 trials) and "NSCLC" (1 trials). Many other conditions were trialed in "NYU Langone Hospital-Long Island Oncology" in a lesser frequency.

Most popular intervention types in "NYU Langone Hospital-Long Island Oncology" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AMN107" (1 trials), "ASA404" (1 trials), "Cisplatin" (1 trials) and "Intensity Modulation Radiation Therapy (IMRT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "NYU Langone Hospital-Long Island Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "NYU Langone Hospital-Long Island Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in NYU Langone Hospital-Long Island Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Langone Hospital-Long Island Oncology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".